Business Context and Reporting Period
Company: Acadia Healthcare Company, Inc. (ACHC)
Filing Type: Form 8-K (Current Report)
Date: January 13, 2026
Context: The filing announces the Company's participation in the 44th Annual J.P. Morgan Healthcare Conference and provides a reaffirmation of its 2025 financial guidance. Acadia operates acute inpatient psychiatric facilities, specialty treatment centers, and outpatient behavioral healthcare services across the U.S. and Puerto Rico.
Key Financial Metrics and Guidance
This filing does not report historical financial results for a specific period but reaffirms the full-year 2025 financial guidance previously issued in November and December 2025.
- Revenue (2025): $3.28 billion to $3.30 billion
- Adjusted EBITDA (2025): $601 million to $611 million
- Adjusted Earnings Per Share (2025): $1.94 to $2.04
Note: The filing text does not provide current period revenue, profit, cash flow, margins, debt, or liquidity figures. These metrics are referenced only within the context of the 2025 forward-looking guidance.
Material Changes and Outlook
Guidance Update: Management is reaffirming the 2025 financial guidance without modification from the December 2, 2025 update.
Conference Presentation: A live webcast of the presentation was scheduled for January 13, 2026, at 5:15 p.m. Pacific Time, with slides furnished as Exhibit 99.
Risks and Contingencies
The filing highlights several material risks that could cause actual results to differ from forward-looking statements:
- Regulatory and Legislative Changes: Significant changes to Medicaid financing mechanisms introduced by the "One Big Beautiful Bill Act" (OBBBA) enacted on July 4, 2025, including potential payment reductions and new work/community engagement requirements for the Medicaid expansion population.
- Operational Risks: Difficulties in integrating acquired facilities, realizing synergies, adding beds, or improving efficiencies.
- Legal and Compliance: Risks related to patient incidents, governmental investigations, litigation, and adverse regulatory actions.
- Financial Risks: Potential inability to generate sufficient cash from operations to service debt and meet capital expenditure requirements.
- External Factors: Cybersecurity incidents, labor and supply chain cost increases, and general economic disruptions.
Investor Verification Checklist
- Verify the specific impact of the "One Big Beautiful Bill Act" (OBBBA) on Medicaid reimbursement rates and patient volume.
- Review the detailed slide presentation (Exhibit 99) for granular data on facility expansion and integration progress.
- Monitor subsequent filings for actual 2025 results to compare against the reaffirmed guidance ranges.
- Assess the Company's liquidity position and debt service capabilities given the noted risks regarding cash flow generation.